In Section A, contributors will obtain distinctive doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Supplemental contributors will likely be enrolled at the recognized monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 will probably be supplied as "add-on" therapy. In Segment https://davidk665xis8.birderswiki.com/user